Skip to content
Clinical Trials – home

Spitalul Clinic De Boli Infectioase Si Pneumoftiziologie Victor Babes Craiova

Verified siteinfo

Romania Strada Calea Bucuresti Nr. 64 Fost 126, 200515 Craiova, Romania

  • 5 trials recruiting
  • Asthma · Chronic obstructive pulmonary disease · Idiopathic pulmonary fibrosis
  • Adults and children

About Specializations

Spitalul Clinic De Boli Infectioase Si Pneumoftiziologie Victor Babes Craiova in Craiova, Romania specialises in clinical trials of conditions such as Asthma, Chronic obstructive pulmonary disease, Idiopathic pulmonary fibrosis, Chronic hepatitis B, and other specialisations. This site conducts important research.

Main research areas of the site

Respiratory Tract Diseases

At Spitalul Clinic De Boli Infectioase Si Pneumoftiziologie Victor Babes Craiova, the strongest research focus is on respiratory diseases, especially asthma, chronic obstructive pulmonary disease (COPD), and idiopathic pulmonary fibrosis. The studies are mainly designed to test new inhaled or targeted therapies, compare treatment options, and improve control of symptoms and flare-ups.

  • Asthma research covering mild, moderate, and severe forms, including eosinophilic and uncontrolled disease
  • COPD studies focused on reducing exacerbations and improving lung function
  • Idiopathic pulmonary fibrosis research aimed at slowing loss of breathing capacity

This Pneumologie department in Craiova is contributing to clinical trials that seek better long-term management and more effective respiratory care.

Immune System Diseases

The site also conducts research in immune system diseases, with a notable emphasis on asthma as an inflammatory condition. These trials are exploring whether newer therapies can better reduce airway inflammation, prevent worsening disease, and support more stable breathing over time.

  • Moderate-to-severe asthma
  • Uncontrolled moderate to severe eosinophilic asthma
  • Controlled and partly controlled asthma

Overall, the research aims to improve day-to-day disease control and lower the risk of future attacks for patients treated at this hospital.

Virus Diseases

Another important area of research is virus diseases, especially COVID-19 and hepatitis B infection. The trials are evaluating whether new antiviral or immune-based approaches can improve outcomes, reduce complications, and support better disease management.

  • COVID-19 studies focused on lowering hospitalization and death in outpatients
  • Chronic hepatitis B research examining antiviral and immune response strategies
  • Pediatric hepatitis B studies looking at treatment effectiveness and viral control

These investigations reflect the site’s role in addressing both acute and long-term infectious diseases through clinical research.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Strada Calea Bucuresti Nr. 64 Fost 126200515 CraiovaRomania
Recruiting now
5 trials
Conditions studied
5
Partner status
Verified site

More sites in CraiovaRomania

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

20 clinical trials

Study of Brenipatide (LY3537031) in Adults with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:LY3537031
  • Sponsor:Eli Lilly & Co.

Asthma

Recruiting

Study of Three Doses of Frevecitinib (KN-002) in Adults with Severe Asthma Not Controlled by Medium‑to‑High Dose Inhaled Steroid/LABA Therapy

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol Sulfate

Asthma

Recruiting

Efficacy and Safety of Depemokimab for Early Intervention in Adults and Adolescents with Type 2 Asthma at Risk of Exacerbations

Registered drug
Countries:RomaniaRomania
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited

Asthma

Recruiting

GB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents

Investigational
Countries:RomaniaRomania
  • Participants:0–17 years · 18–64 years · 65+ years
  • Sponsor:Generate Biomedicines Inc.

Asthma

Recruiting

A study to evaluate the effects of KT-621 in adults with moderate to severe eosinophilic asthma

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Sponsor:Kymera Therapeutics Inc.

Asthma

Not yet recruiting

Asthma in adults: beclometasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium bromide compared with beclometasone dipropionate and formoterol fumarate dihydrate

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Beclometasone Dipropionate
  • Sponsor:Chiesi Farmaceutici S.p.A.

Randomized Phase 3 Study of Deupirfenidone (LYT‑100) versus Pirfenidone in Adults with Idiopathic Pulmonary Fibrosis

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Deupirfenidone
  • Sponsor:Puretech Lyt 100 Inc.

Asthma

Not yet recruiting

Long‑Term Safety and Tolerability Study of Oral KT‑621 in Adults with Uncontrolled Moderate‑to‑Severe Eosinophilic Asthma

InvestigationalNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Sponsor:Kymera Therapeutics Inc.

A study to evaluate the safety and effectiveness of zampilimab in people with idiopathic pulmonary fibrosis

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Zampilimab
  • Sponsor:Chiesi Farmaceutici S.p.A.

Asthma

Not recruiting

Study on the Effectiveness and Safety of Fluticasone Propionate and Salbutamol Sulfate for Asthma in Patients Aged 12 and Older

Investigational
Countries:RomaniaRomania
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:Teva Branded Pharmaceutical Products R&D LLC

Study on the Effectiveness and Safety of Tanimilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Tanimilast
  • Sponsor:Chiesi Farmaceutici S.p.A.

Asthma

Not recruiting

Study of rocatinlimab compared to placebo to help adults with Moderate to Severe Asthma

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.